Arinsoy T - Search Results

1

Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator.

Ozdemir O, Arik N, Ozcebe O, Arinsoy T, Sungur C, Dündar S, Turgan C, Yasavul U, Cağlar S, Kirazli S. Ozdemir O, et al. Among authors: arinsoy t. Thromb Res. 1992 Sep 15;67(6):697-704. doi: 10.1016/0049-3848(92)90073-j. Thromb Res. 1992. PMID: 1440534

2

Recombinant human erythropoietin treatment may induce antithrombin-III depletion.

Arinsoy T, Ozdemir O, Arik N, Ozcebe O, Yasavul U, Dündar S, Turgan C, Kirazli S, Cağlar S. Arinsoy T, et al. Nephron. 1992;62(4):480-1. doi: 10.1159/000187110. Nephron. 1992. PMID: 1300451 Free article. No abstract available.

3

Uterine technetium-99m mercaptoacetyltriglycine and diethylene triamine penta-acetic acid uptake in the scintigraphic evaluation of transplanted kidneys.

Erbas B, Arinsoy T, Ugur O, Varoglu E, Arik N, Bekdik CF. Erbas B, et al. Among authors: arinsoy t. Eur J Nucl Med. 1992;19(5):375-7. doi: 10.1007/BF00177061. Eur J Nucl Med. 1992. PMID: 1535316

4

Protein C and its inhibitors during hemodialysis.

Arik N, Ozdemir O, Akpolat T, Arinsoy T, Ozcebe O, Dündar S, Yasavul U, Turgan C, Caglar S. Arik N, et al. Among authors: arinsoy t. Nephron. 1992;60(4):488. doi: 10.1159/000186815. Nephron. 1992. PMID: 1584328 Free article. No abstract available.

5

Acute effect of erythropoietin on plasma renin activity and aldosterone levels in end-stage renal disease.

Arik N, Demirkan F, Erbas B, Arinsoy T, Sungur C, Yasavul U, Turgan C, Koray Z, Caglar S. Arik N, et al. Among authors: arinsoy t. Nephron. 1992;60(1):111. doi: 10.1159/000186715. Nephron. 1992. PMID: 1738400 Free article. No abstract available.

6

Hemodialysis-induced hypoxemia and fibronectin.

Arik N, Ozdemir O, Sayin M, Arinsoy T, Bariş I, Dündar S, Taşdemir I, Turgan C, Yasavul U, Caglar S. Arik N, et al. Among authors: arinsoy t. Nephron. 1991;59(1):162-3. doi: 10.1159/000186540. Nephron. 1991. PMID: 1944735 Free article. No abstract available.

7

Famotidine reduces serum parathyroid hormone levels in uremic patients.

Arik N, Arinsoy T, Sayín M, Taşdemir I, Yasavul U, Turgan C, Caglar S. Arik N, et al. Among authors: arinsoy t. Nephron. 1991;59(2):333. doi: 10.1159/000186580. Nephron. 1991. PMID: 1956503 Free article. No abstract available.

8

Membranoproliferative glomerulonephritis presenting with hypokalemia.

Ozdemir O, Taşdemir I, Arinsoy T, Yasavul U, Turgan C, Caglar S. Ozdemir O, et al. Among authors: arinsoy t. Nephron. 1990;54(4):362-3. doi: 10.1159/000185901. Nephron. 1990. PMID: 2325807 Free article. No abstract available.

9

High prevalence of antibodies to hepatitis C virus among renal transplant recipients: correlation with chronic liver dysfunction.

Akpolat T, Arik N, Arinsoy T, Sungur C, Bakkaloglu M, Erkan I, Yasavul U, Turgan C, Caglar S. Akpolat T, et al. Among authors: arinsoy t. Nephron. 1993;64(1):163-4. doi: 10.1159/000187305. Nephron. 1993. PMID: 7684826 Free article. No abstract available.

10

Sudden hearing loss in a cyclosporin-treated renal transplantation patient.

Arinsoy T, Akpolat T, Ataman M, Arik N, Sungur C, Yasavul U, Turgan C, Caglar S. Arinsoy T, et al. Nephron. 1993;63(1):116-7. doi: 10.1159/000187158. Nephron. 1993. PMID: 8446241 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters